OR WAIT null SECS
June 19, 2019
New CDMO facility supports early-stage API manufacturing and scale up.
June 17, 2019
Two additional production lines expand Lonza’s HPAPI capacity at Visp, Switzerland facility.
May 16, 2019
The acquisition of GlaxoSmithKline’s manufacturing site in Cork, Ireland, will expand Thermo Fisher Scientific’s global footprint for complex API manufacturing.
April 30, 2019
The investment will increase patient-centric dosage form manufacturing capabilities at Catalent’s Winchester, KY, facility.
April 23, 2019
Cambrex’s expanded quality control laboratory supports generic API development.
April 02, 2019
Supplier vetting and monitoring-plus comprehensive testing-ensure quality of raw materials.
March 19, 2019
A $100-million investment will expand a range of the CDMO’s service capabilities and offerings.
March 18, 2019
The expansion includes a new R&D laboratory and the installation of a 12,000-liter reactor at one of the company’s manufacturing facilities on its Paullo site in Milan, Italy.
March 01, 2019
GHO Capital, a European specialist investor in healthcare, announced its acquisition of Sterling Pharma Solutions, which specializes in complex and difficult-to-manufacture APIs.
February 01, 2019
Suppliers set the tone for 2019 with strategic expansions, investments, and acquisitions.